JNB Co., Ltd. (KOSDAQ:452160)
South Korea · Delayed Price · Currency is KRW 3,335.00
+250.00 (8.10%)
At close: Jun 29, 2026
JNB Co., Ltd. Revenue
JNB Co., Ltd. had revenue of 3.54B KRW in the quarter ending March 31, 2026, a decrease of -19.46%. This brings the company's revenue in the last twelve months to 14.05B, down -14.43% year-over-year. In the year 2025, JNB Co., Ltd. had annual revenue of 14.90B, down -7.06%.
Revenue (ttm)
14.05B
Revenue Growth
-14.43%
P/S Ratio
2.28
Revenue / Employee
219.46M
Employees
64
Market Cap
32.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.90B | -1.13B | -7.06% |
| Dec 31, 2024 | 16.03B | 719.86M | 4.70% |
| Dec 31, 2023 | 15.31B | -1.24B | -7.48% |
| Dec 31, 2022 | 16.55B | 1.94B | 13.29% |
| Dec 31, 2021 | 14.61B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mirae Asset Vision Special Purpose Acquisition 2 Company | 104.86B |
| ALT Co., Ltd. | 88.13B |
| Bio Port Korea | 75.40B |
| New Kids On | 47.64B |
| ERCOHS Agricultural Corporation Co.,Ltd | 36.23B |
| ADforus | 30.10B |
| Laseroptek | 26.79B |
| Cellromax Science | 20.98B |